This one-day online event will feature short talks covering recent innovations in research and technology in the cell and gene therapy domain. Our expert panel of presenters will address key advances across the entire R&D pipeline, from pre-clinical work right through to bioprocessing and manufacturing.

An incredible opportunity to ask the Chief Editor of Nature on how to get published in high-ranking journals.

New for 2023, this online event will provide researchers with an opportunity to learn about how spatial biology is helping us to gain a deeper understanding of molecular biology and mechanisms of disease. Speakers will discuss advances in spatial technologies and how they are being applied to provide a more complete picture of cells and complex biological systems in areas such as cancer research and neuroscience.

This webinar will introduce a novel method for parent-of-origin-aware genomic analysis using the long-read capabilities of nanopore sequencing and single-cell DNA template strand sequencing to assign variants to each biological parent with 99% accuracy using only a blood research sample from the child.

Protein stability is one of the most important critical quality attributes for a new biological drug. Unstable or misfolded proteins are prone to aggregation and precipitation, which can lead to lower activity as well as increased immunogenicity. There has been a long-standing interest in renaturing unfolded, misfolded or precipitated proteins.

In this webinar, our expert speakers will demonstrate how thermal and pressure stress changed the structure and melting point of two model proteins and resulted in the discovery of different structural rearrangements.

They will then discuss a novel method for solubilizing and refolding proteins using hydrostatic pressure to generate proteins whose structure matches that of the native protein, as confirmed by microfluidic modulation spectroscopy.

Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific subtypes and their reprogramming may influence therapy efficiency.